Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Best practices for using PCR to diagnose Haemophilus influenzae and Neisseria meningitidis and identify serotype or serogroup
  • Published Date:
    June 17, 2016
  • Series:
    HAN ; 391
  • Language:
    English
Filetype[PDF-59.61 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    June 17, 2016, 13:30 EDT (1:30 PM EDT) CDCHAN-00391 Determining serotype for Haemophilus influenzae (Hi) and serogroup for Neisseria meningitidis (Nm) is crucial for identifying potential outbreaks and determining appropriate public health responses. Several new commercial multiplex polymerase chain reaction (PCR) assays capable of simultaneously testing a single specimen for an array of pathogens that cause blood infections, meningitis, or encephalitis are available. These assays can rapidly identify Hi and Nm species, but most do not determine serotype or serogroup. Laboratories should continue to perform culture and use validated, specific real-time PCR assays capable of detecting and differentiating all six serotypes (a-f) of Hi and six serogroups (A, B, C, W, X, and Y) of Nm; otherwise, additional steps need to be taken including performing a reflex culture or at a minimum retaining a clinical sample for further testing. FINAL HAN 391 Best Practices for Using PCR to Diagnose Haemophilus influenzae and Neisseria Mening_06 17 16.pdf
  • Subject:
  • Document Type:
    HAN Health Advisory
  • Place as Subject:
    United States
  • Collection(s):
    Health Alert Network (HAN)
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR
    Personal Author:
    Kim, So Yeon; Lee, Jaehyeon; Sung, Heungsup; Lee, Hyukmin; Han, Myung Guk; Yoo, Cheon Kwon; Lee, Sang Won; Hong, Ki Ho;
    Published Date:
    August 26 2020
    Source:
    Emerg Infect Dis. 26(10):2469-2472
    Description:
    To validate the specimen-pooling strategy for real-time reverse transcription PCR detection of severe acute respiratory syndrome coronavirus 2, we generated different pools including positive specimens, reflecting the distribution of cycle threshold ...
    File Type:
    Filetype[PDF - 635.45 KB]
  2. Coming Soon
    Zika Virus Disease and Pregnancy Outcomes in Colombia
    Personal Author:
    Ospina, Martha L.; Tong, Van T.; Gonzalez, Maritza; Valencia, Diana; Mercado, Marcela; Gilboa, Suzanne M.; Rodriguez, Andrea J.; Tinker, Sarah C.; Rico, Angelica; Winfield, Christina M.; Pardo, Lissethe; Thomas, Jennifer D.; Avila, Greace; Villanueva, Julie M.; Gomez, Sara; Jamieson, Denise J.; Prieto, Franklyn; Meaney-Delman, Dana; Pacheco, Oscar; Honein, Margaret A.;
    Published Date:
    August 06 2020
    Source:
    N Engl J Med. 383(6):537-545
    Description:
    BACKGROUNDIn 2015 and 2016, Colombia had a widespread outbreak of Zika virus. Data from two national population-based surveillance systems for symptomatic Zika virus disease (ZVD) and birth defects provided complementary information on the effect of ...
    Public Access
    Available on:
    August 06, 2021
  3. Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea
    Personal Author:
    Sung, Heungsup; Han, Myung-Guk; Yoo, Cheon-Kwon; Lee, Sang-Won; Chung, Yoon-Seok; Park, Jae-Sun; Kim, Mi-Na; Lee, Hyukmin; Hong, Ki Ho; Seong, Moon-Woo; Lee, Kyunghoon; Chun, Sail; Lee, Wee Gyo; Kwon, Gye-Cheol; Min, Won-Ki;
    Published Date:
    July 29 2020
    Source:
    Emerg Infect Dis. 26(10):2353-2360
    Description:
    External quality assessment (EQA) is essential for ensuring reliable test results, especially when laboratories are using assays authorized for emergency use for newly emerging pathogens. We developed an EQA panel to assess the quality of real-time r...
    File Type:
    Filetype[PDF - 1.26 MB]
  4. CDC’s diagnostic test for COVID-19 only and supplies
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    July 15, 2020
    Description:
    Updated July 15, 2020In addition to this test, CDC has developed a diagnostic test that can be used to detect SARS-CoV-2, influenza A, and influenza B viruses at the same time. This test is called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assa...
    File Type:
    Filetype[PDF - 126.41 KB]
  5. Research use only CDC influenza SARS-CoV-2 (Flu SC2) multiplex assay real-Time RT-PCR primers and probes
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. Virology Surveillance and Diagnosis Branch. Genomics and Diagnostics Team..
    Published Date:
    July 14, 2020
    Description:
    NOT FOR VIRAL TESTING USEReagents manufactured from these sequences may not be used for viral testing under FDA’s authorization of the Flu SC2 Multiplex Assay.Only primers and probes labeled for EUA use and distributed by the International Reagent ...
    File Type:
    Filetype[PDF - 210.67 KB]